The Discrepancy between Preoperative Tumor Markers and Imaging Outcomes in Predicting Ovarian Malignancy
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q2
- 저널
- CANCERS14(23) · #5821 · 2022
- 피인용
- Web of Science 5Scopus 5
- FWCI (Scopus)
- 0.31
- JCR IF
- JCR 2021 6.575
- ISSN
- 2072-6694
저자
- 신경화제1저자Pusan Natl Univ, Dept Lab Med, Sch Med, Busan 49241, South Korea
- 김형회Pusan Natl Univ, Dept Lab Med, Sch Med, Busan 49241, South Korea
- 윤형준Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
- 김은택Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
- 서동수Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
- 김기형교신저자Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
초록
Simple Summary Preoperative tumor markers and imaging often differ in predicting whether an ovarian tumor is malignant. We evaluated the correlation between the predictive values of imaging and tumor markers for diagnosing ovarian tumors, especially when there were discrepancies between the two. We found that, to prevent misidentification, it is necessary to understand the underlying disease that can increase tumor marker levels or benign tumors, which are difficult to distinguish from malignant tumors in imaging tests and several rare histopathologies with low risk of ovarian malignancy algorithm values. The malignant prediction of tumor markers and imaging was different in many patients with ovarian tumors, and this study will help to reduce the misidentification of tumors. Preoperative tumor markers and imaging often differ in predicting whether an ovarian tumor is malignant. Therefore, we evaluated the correlation between the predictive values of imaging and tumor markers for diagnosing ovarian tumors, especially when there were discrepancies between the two. We enrolled 1047 patients with ovarian tumors. The predictive values and concordance rates between the preoperative risk of ovarian malignancy algorithm (ROMA) and imaging, including CT and MRI, were evaluated. Diagnoses of 561 CT (77.9%) and 322 MRI group (69.2%) participants were consistent with the ROMA. Among them, 96.4% of the CT (541/561) and 92.5% of the MRI (298/322) group predicted an accurate diagnosis. In contrast, 67.3% (101/150) of CT and 75.2% (100/133) of MRI cases accurately predicted the diagnosis in cases with discrepancies between ROMA and CT or MRI; a total of 32% (48/150) of the CT and 25.5% (34/133) of the MRI group showed an accurate ROMA diagnosis in cases with discrepancies between ROMA and imaging. In the event of a discrepancy between ROMA and imaging when ovarian tumor malignancy prediction, the question is which method should take precedence. This study demonstrates that MRI has the greatest diagnostic accuracy, followed by CT and ROMA. It is also important to understand underlying diseases and benign conditions and rare histopathologies of malignant tumors.
키워드
ovarian cancerpreoperative tumor markersCTMRICANCERMANAGEMENTBENIGNHE-4DIAGNOSIS
식별자
- Scopus EID
- 2-s2.0-85143604134
- WoS UID
- 000897348400001



로그인
연구물 목록으로